Rugo HS - Search Results

1

Capivasertib and fulvestrant for patients with hormone receptor-positive, HER2-negative advanced breast cancer (CAPItello-291): patient-reported outcomes from a phase 3, randomised, double-blind, placebo-controlled trial.

Oliveira M, Rugo HS, Howell SJ, Dalenc F, Cortes J, Gomez HL, Hu X, Toi M, Jhaveri K, Krivorotko P, Loibl S, Morales Murillo S, Okera M, Nowecki Z, Park YH, Sohn JH, Tokunaga E, Yousef S, Zhukova L, Fulford M, Andrews H, Wadsworth I, D'Cruz C, Turner NC; CAPItello-291 study group. Oliveira M, et al. Among authors: rugo hs. Lancet Oncol. 2024 Sep;25(9):1231-1244. doi: 10.1016/S1470-2045(24)00373-5. Lancet Oncol. 2024. PMID: 39214106 Clinical Trial.

2

Busulfan plus etoposide as a preparative regimen for autologous bone marrow transplantation for acute myelogenous leukemia: an update.

Linker CA, Damon LE, Ries CA, Rugo HS, Wolf JL. Linker CA, et al. Among authors: rugo hs. Semin Oncol. 1993 Aug;20(4 Suppl 4):40-8; quiz 49. Semin Oncol. 1993. PMID: 8342075

3

The impact of adjuvant therapy for breast cancer on cognitive function: current evidence and directions for research.

Rugo HS, Ahles T. Rugo HS, et al. Semin Oncol. 2003 Dec;30(6):749-62. doi: 10.1053/j.seminoncol.2003.09.008. Semin Oncol. 2003. PMID: 14663776 Review.

4

High-dose etoposide, thiotepa, and dose-adjusted carboplatin (TVCa) with autologous hematopoietic stem cell rescue as treatment of relapsed or refractory germ cell cancer.

Chaudhary UB, Damon LE, Rugo HS, Linker CA, Navarro W, Small EJ. Chaudhary UB, et al. Among authors: rugo hs. Am J Clin Oncol. 2005 Apr;28(2):130-7. doi: 10.1097/01.coc.0000144264.00518.47. Am J Clin Oncol. 2005. PMID: 15803005 Clinical Trial.

5

Phase I trial of the oral antiangiogenesis agent AG-013736 in patients with advanced solid tumors: pharmacokinetic and clinical results.

Rugo HS, Herbst RS, Liu G, Park JW, Kies MS, Steinfeldt HM, Pithavala YK, Reich SD, Freddo JL, Wilding G. Rugo HS, et al. J Clin Oncol. 2005 Aug 20;23(24):5474-83. doi: 10.1200/JCO.2005.04.192. Epub 2005 Jul 18. J Clin Oncol. 2005. PMID: 16027439 Clinical Trial.

6

Hormonal therapy for advanced breast cancer.

Rugo HS. Rugo HS. Hematol Oncol Clin North Am. 2007 Apr;21(2):273-91. doi: 10.1016/j.hoc.2007.03.007. Hematol Oncol Clin North Am. 2007. PMID: 17512449 Review.

7

Bevacizumab for advanced breast cancer.

Traina TA, Rugo HS, Dickler M. Traina TA, et al. Among authors: rugo hs. Hematol Oncol Clin North Am. 2007 Apr;21(2):303-19. doi: 10.1016/j.hoc.2007.03.006. Hematol Oncol Clin North Am. 2007. PMID: 17512451 Review.

8

The importance of distant metastases in hormone-sensitive breast cancer.

Rugo HS. Rugo HS. Breast. 2008 Jan;17 Suppl 1:S3-8. doi: 10.1016/S0960-9776(08)70002-X. Breast. 2008. PMID: 18279764 Review.

9

Brain metastases in breast cancer: clinical and pathologic characteristics associated with improvements in survival.

Melisko ME, Moore DH, Sneed PK, De Franco J, Rugo HS. Melisko ME, et al. Among authors: rugo hs. J Neurooncol. 2008 Jul;88(3):359-65. doi: 10.1007/s11060-008-9578-5. Epub 2008 Apr 9. J Neurooncol. 2008. PMID: 18398574

10

New challenges and opportunities in the management of brain metastases in patients with ErbB2-positive metastatic breast cancer.

Melisko ME, Glantz M, Rugo HS. Melisko ME, et al. Among authors: rugo hs. Nat Clin Pract Oncol. 2009 Jan;6(1):25-33. doi: 10.1038/ncponc1243. Epub 2008 Oct 21. Nat Clin Pract Oncol. 2009. PMID: 18936791 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

566 results

Search Page

Filters